Potentiating CD20 monoclonal antibody therapy by targeting complement C3 fragment covalently deposited on lymphoma cells.
Baskar S, Peng H, Gaglione EM, Carstens EJ, Lindorfer MA, Ahn IE, Herman SEM, Skarzynski M, Chang J, Keyvanfar K, Butera V, Blackburn AZ, Vire B, Maric I, Stetler-Stevenson M, Yuan CM, Eckhaus MA, Soto S, Farooqui MZH, Taylor RP, Rader C, Wiestner A.
Baskar S, et al. Among authors: peng h.
Blood. 2025 Jan 7:blood.2024024846. doi: 10.1182/blood.2024024846. Online ahead of print.
Blood. 2025.
PMID: 39774793